Filing Flows › Usana Health Sciences (USNA) › Guidance history
Usana Health Sciences (USNA) guidance history: what it guided and what it reported
Usana Health Sciences gave guidance in 3 earnings releases on file since May 5, 2026. Its releases raised guidance 0 times and lowered it twice.
Revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $720M–$765M (May 5, 2026) → raised $750M (Aug 4, 2026) → lowered $740M (Nov 3, 2026) | — | to be reported | — |
Adjusted revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $900M (Nov 3, 2026) | — | to be reported | — |
Net income
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $20.0M–$27.0M (May 5, 2026) | — | to be reported | — |
Adjusted EPS
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | −$1.00 (May 5, 2026) → reaffirmed −$1.00 (Aug 4, 2026) → reaffirmed −$1.00 (Nov 3, 2026) | — | to be reported | — |
Adjusted EBITDA
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $77.0M (Nov 3, 2026) | — | to be reported | — |
The latest quarter
Usana Health Sciences, Q2 2026: revenue $223M (-5% year over year), operating margin -9.0%, net loss $28.0M, operating cash flow $23.3M. The chart follows the revenue to costs, profit and cash.
Questions
Does Usana Health Sciences beat its guidance?
Usana Health Sciences gave guidance in 3 earnings releases on file since May 5, 2026. Its releases raised guidance 0 times and lowered it twice.
How often does Usana Health Sciences raise guidance?
Its earnings releases raised guidance 0 times and lowered it twice since May 5, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.